Jasper Ridge Partners, L.P. Mirum Pharmaceuticals, Inc. Transaction History
Jasper Ridge Partners, L.P.
- $3.5 Billion
- Q3 2024
A detailed history of Jasper Ridge Partners, L.P. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Jasper Ridge Partners, L.P. holds 8,206 shares of MIRM stock, worth $401,109. This represents 0.01% of its overall portfolio holdings.
Number of Shares
8,206
Previous 8,206
-0.0%
Holding current value
$401,109
Previous $280,000
14.29%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
193Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$321 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$219 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$168 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$158 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$150 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.8B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...